My guess is ---------3 Jan 2024 14:04
--------that Avacta will "launch" themselves and their Precision and Affimer platforms, to the USA and the rest of the world, either at the J P Morgan Healthcare conference ( San Francisco 8-11th Jan24) or at the AACR (San Diego 5-10th April24).
This would all tie in with the very strong USA connections evidenced by Orphan Drug Designation, FDA approvals and possible fast tracking, the MSK trials and the Dr Tap association, the Dr Christina Coughlin engagement, the Fred Hutch trials together with the ICR Consilium Stateside connections etc.
Noted that Tony Blair is down as a keynote speaker at the J P Morgan conference which sits happily ( in my view) with AS's distrust of the current HMG, its associated corruption, cronyism and shabby treatment of UK Life Science companies during the Covid crisis.
Perhaps therefore we have about 12 weeks max to wait for a significant rerate of the SP, but it could be earlier.